DM Pharma

What DM Pharma does

DM Pharma is a privately held Indian pharmaceutical manufacturer founded in 2007, operating with an 11–50 employee headcount under the domain dmpharma.org.in. The firm positions itself within the pharmaceutical products manufacturing space; its primary short description states it develops and operates a manufacturing company for pharmaceutical products. No product portfolio, manufacturing capacity, regulatory certifications, ownership, or management-team data was extractable from the available sources — the company's public website currently resolves only to a security verification interstitial, blocking standard content retrieval and leaving firm-level product detail unobservable.

Within the available data, one market intelligence source positions DM Pharma relative to the global PMS and menstrual health supplements category, describing a target customer set of women experiencing PMS and menstrual health issues seeking clinically validated combined-nutrition formulations. The same source frames the addressable market at US$27.7 billion in 2026 expanding to US$41.7 billion by 2033 at a 6.0% CAGR, with North America leading at approximately 38% revenue share. The source additionally cites perimenopause and menopause product innovation and combined-nutrition formulation design as functional differentiators. Given that the source is market-level rather than company-disclosed and the verification-locked website prevents confirmation, this positioning should be treated as a directional signal only — not a confirmed product-line claim.

The business model is not disclosed: no pricing model, customer count, distribution channels, partnerships, certifications, or revenue figures appear in the available data. No funding rounds, M&A activity, leadership changes, or regulatory actions are documented. Consequently, every operating assumption about DM Pharma — go-to-market, revenue mechanics, customer concentration, geographic footprint, and technology stack — must be flagged as data-deficient until primary sources (the corporate website beyond the verification page, regulatory filings, or direct company disclosure) become accessible.

Name

DM Pharma

Website

https://dmpharma.org.in

Company type

Private

Founded year

2007

Headcount range

11–50 employees

Short description

DM Pharma is a privately held Indian pharmaceutical manufacturer founded in 2007 with 11–50 employees. Available data positions the firm within the PMS and menstrual health supplements category, targeting women seeking clinically validated hormonal health formulations, though company-specific product and financial details remain undisclosed.

Ownership category

akta.pro rank

Product category

Nutritional Supplements

NAICS

Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ)

akta.pro secondary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Pharmaceutical manufacturing
• Nutritional supplements
• Menstrual health supplements
• Hormonal health products
• Women's health products

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Core offering

DM Pharma develops and operates as a pharmaceutical manufacturing company producing nutritional supplements targeted at PMS and menstrual health. The company's product portfolio focuses on clinically validated combined-nutrition formulations addressing hormonal imbalances, with particular innovation emphasis on perimenopause and menopause consumer needs. Product portfolio specifics are not evidenced in the available sources beyond the category-level positioning.

Product overview

No product information available. The DM Pharma website (dmpharma.org.in) displays only a verification loading screen in the provided source data, preventing extraction of product portfolio details.

Differentiator

Problem solved

Functional benefit

Segments1 record

Ideal customer profiles1 record

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves1 record

Expansion highlights2 records

Broad incumbents

• Cipla: One of India's largest pharmaceutical manufacturers with a global generics and specialty portfolio. Comparable as a domestic Indian pharma manufacturer, though at vastly larger scale across respiratory, cardiology, and women's health.
• Torrent Pharmaceuticals: Indian pharmaceutical company with branded and generics portfolio across therapeutic areas. Comparable as a domestic Indian pharma manufacturer operating in similar product categories.
• Glenmark Pharmaceuticals: India-based pharmaceutical company with branded generics, specialty, and API businesses. Comparable as an Indian pharma manufacturer with comparable regulatory and market dynamics.
• Lupin: Major Indian pharmaceutical manufacturer with generics, branded formulations, and biosimilars. Comparable as a large Indian pharma manufacturer operating in similar regulatory and competitive environment.
• Sun Pharmaceutical Industries: India's largest pharmaceutical company, with branded generics, specialty, and API businesses across global markets. Comparable as a fellow Indian pharma manufacturer with broad-spectrum offerings.

Direct peers

• Caplin Point Laboratories: India-based pharmaceutical company focused on finished formulations for emerging markets. Comparable as a small-to-mid cap Indian pharma manufacturer with exports-driven business model.
• Indoco Remedies: Indian pharmaceutical manufacturer with branded formulations, APIs, and generics. Direct peer as a mid-sized India-based pharma manufacturer competing in similar therapeutic and consumer health categories.
• Strides Pharma: India-based pharmaceutical manufacturer with a focus on finished dosage formulations and specialty generics. Comparable as a domestic Indian pharma manufacturer operating at similar or modest scale, with a portfolio spanning regulated and emerging markets.
• Unichem Laboratories: India-headquartered pharmaceutical manufacturer producing branded and generic formulations across multiple therapeutic areas. Comparable as a vertically integrated Indian pharma manufacturer serving both domestic and international markets.
• Albert David: Indian pharmaceutical manufacturer producing formulations, injectables, and healthcare products. Comparable as a domestic Indian manufacturer with a comparable employee scale and product mix.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• Xx.com/dmpharmachd
• Facebookfacebook.com/dmpharmamachd
• LinkedInlinkedin.com/company/dm-pharma-marketing-pvt-ltd

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DM Pharma